North Star Investment Management’s abrdn Life Sciences Investors HQL Stock Holding History

North Star Investment Management’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,415	Closed	-$27K	–	1106
2018 Q1	$27K	Buy	1,415 +29	+2%	+$581	﹤0.01%	679
2017 Q4	$27K	Buy	1,386 +30	+2%	+$601	﹤0.01%	665
2017 Q3	$29K	Buy	1,356 +26	+2%	+$552	﹤0.01%	647
2017 Q2	$28K	Buy	1,330 +25	+2%	+$505	﹤0.01%	640
2017 Q1	$25K	Buy	1,305 +24	+2%	+$445	﹤0.01%	642
2016 Q4	$22K	Buy	1,281 +30	+2%	+$527	﹤0.01%	625
2016 Q3	$23K	Buy	1,251 +51	+4%	+$961	﹤0.01%	520
2016 Q2	$21K	Buy	1,200 +22	+2%	+$406	﹤0.01%	528
2016 Q1	$21K	Buy	1,178 +64	+6%	+$1.16K	﹤0.01%	501
2015 Q4	$26K	Buy	+1,114	New	+$27.6K	0.01%	467
2014 Q3	–	Sell	-1,010	Closed	-$21K	–	651
2014 Q2	$21K	Buy	+1,010	New	+$21.2K	﹤0.01%	482

Other funds holding HQL

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

CAN

Claraphi Advisory Network Aliso Viejo, United States $251M AUM 9.29% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

North Star Investment Management's HQL Position: Q2 2018 in Review

North Star Investment Management sold out of abrdn Life Sciences Investors (HQL) in Q2 2018, closing a stake of 1,415 shares — an estimated $27K sold.

North Star Investment Management first reported a position in HQL in Q2 2014 and held it in 11 quarters. The position peaked at $29K in Q3 2017. 59 funds tracked by Wall St. Rank hold HQL as of Q2 2018.

North Star Investment Management reported no remaining abrdn Life Sciences Investors position as of Q2 2018 after selling out during the quarter.
North Star Investment Management sold 1,415 abrdn Life Sciences Investors shares in Q2 2018, an estimated $27K.
North Star Investment Management first reported a position in abrdn Life Sciences Investors in Q2 2014 and held it in 11 quarters.
North Star Investment Management's abrdn Life Sciences Investors position peaked at $29K in Q3 2017.
59 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2018.

Based on North Star Investment Management's 13F filing for Q2 2018, filed 20 Jul 2018.